Key Details
Price
$1.67Annual ROE
-142.50%Beta
0.92Events Calendar
Next earnings date:
Mar 7, 2025Recent quarterly earnings:
Nov 14, 2024Recent annual earnings:
Mar 7, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Mar 17, 2021Analyst ratings
Recent major analysts updates
Feb 20, 25 Maxim Group
BuyNov 15, 24 Oppenheimer
OutperformMay 13, 24 Maxim Group
BuyMay 6, 24 Oppenheimer
OutperformMar 8, 24 Oppenheimer
PerformOct 6, 23 Roth MKM
BuyJun 7, 23 Oppenheimer
PerformApr 18, 23 Oppenheimer
OutperformMar 10, 22 Oppenheimer
OutperformDec 7, 21 Aegis Capital
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Chemomab Therapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Chemomab Therapeutics?
- Does Chemomab Therapeutics pay dividends?
- What sector is Chemomab Therapeutics in?
- What industry is Chemomab Therapeutics in?
- What country is Chemomab Therapeutics based in?
- When did Chemomab Therapeutics go public?
- Is Chemomab Therapeutics in the S&P 500?
- Is Chemomab Therapeutics in the NASDAQ 100?
- Is Chemomab Therapeutics in the Dow Jones?
- When was Chemomab Therapeutics's last earnings report?
- When does Chemomab Therapeutics report earnings?
- Should I buy Chemomab Therapeutics stock now?
What is the ticker symbol for Chemomab Therapeutics?
The ticker symbol for Chemomab Therapeutics is NASDAQ:CMMB
Does Chemomab Therapeutics pay dividends?
No, Chemomab Therapeutics does not pay dividends
What sector is Chemomab Therapeutics in?
Chemomab Therapeutics is in the Healthcare sector
What industry is Chemomab Therapeutics in?
Chemomab Therapeutics is in the Biotechnology industry
What country is Chemomab Therapeutics based in?
Chemomab Therapeutics is headquartered in Israel
When did Chemomab Therapeutics go public?
Chemomab Therapeutics's initial public offering (IPO) was on February 12, 2019
Is Chemomab Therapeutics in the S&P 500?
No, Chemomab Therapeutics is not included in the S&P 500 index
Is Chemomab Therapeutics in the NASDAQ 100?
No, Chemomab Therapeutics is not included in the NASDAQ 100 index
Is Chemomab Therapeutics in the Dow Jones?
No, Chemomab Therapeutics is not included in the Dow Jones index
When was Chemomab Therapeutics's last earnings report?
Chemomab Therapeutics's most recent earnings report was on Nov 14, 2024
When does Chemomab Therapeutics report earnings?
The next expected earnings date for Chemomab Therapeutics is Mar 7, 2025
Should I buy Chemomab Therapeutics stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions